The genetics of rheumatoid arthritis

LE Dedmon - Rheumatology, 2020 - academic.oup.com
RA is a chronic systemic inflammatory disease that primarily affects the small joints of the
hands and feet, and results in a mean reduction in life expectancy of 3–10 years. RA is a …

Gut microbial metabolism of 5-ASA diminishes its clinical efficacy in inflammatory bowel disease

RS Mehta, JR Mayers, Y Zhang, A Bhosle… - Nature Medicine, 2023 - nature.com
For decades, variability in clinical efficacy of the widely used inflammatory bowel disease
(IBD) drug 5-aminosalicylic acid (5-ASA) has been attributed, in part, to its acetylation and …

Phytochemicals targeting JAK/STAT pathway in the treatment of rheumatoid arthritis: Is there a future?

G Kour, R Choudhary, S Anjum, A Bhagat… - Biochemical …, 2022 - Elsevier
Rheumatoid arthritis (RA) is a chronic autoimmune disorder and the treatment involves the
use of traditional and biological disease modifying anti-rheumatic drugs (DMARDs). Recent …

Arylamine N-acetyltransferase acetylation polymorphisms: paradigm for pharmacogenomic-guided therapy-a focused review

DW Hein, LM Millner - Expert opinion on drug metabolism & …, 2021 - Taylor & Francis
Introduction The N-acetylation polymorphism has been the subject of comprehensive
reviews describing the role of arylamine N-acetyltransferase 2 (NAT2) in the metabolism of …

Progress in the study of ferroptosis in cancer treatment: State-of-the-Art

D Wang - Chemico-Biological Interactions, 2023 - Elsevier
As a regulatory cell death mode defined in recent years, Ferroptosis is mainly characterized
by increased intracellular free iron and the accumulation of lipid peroxides. Ferroptosis is …

[HTML][HTML] Sulfasalazine

J Choi, P Patel, A Fenando - StatPearls [Internet], 2024 - ncbi.nlm.nih.gov
Objectives: Describe the mechanism of action of sulfasalazine. Identify the adverse effects
and contraindications of sulfasalazine. Determine appropriate monitoring steps and toxicity …

[HTML][HTML] Association between NAT2 polymorphism and lung cancer risk: a systematic review and meta-analysis

K Zhu, A Xu, W Xia, P Li, B Zhang, H Jiang… - Frontiers in …, 2021 - frontiersin.org
Lung cancer is the leading cause of cancer-related death worldwide and has a high
incidence rate. N-Acetyltransferase 2 (NAT2) is a polymorphic xenobiotic enzyme, which can …

Genotypic and phenotypic landscapes of 51 pharmacogenes derived from whole-genome sequencing in a Thai population

N Wankaew, P Chariyavilaskul, M Chamnanphon… - Plos one, 2022 - journals.plos.org
Differences in drug responses in individuals are partly due to genetic variations in
pharmacogenes, which differ among populations. Here, genome sequencing of 171 …

Discovery of a novel genetic variant in the N-acetyltransferase2 (NAT2) gene that is associated with bladder cancer risk

L Elsalem, A Al Shatnawi, MA Alfaqih… - Acta Biochimica …, 2023 - abp.ptbioch.edu.pl
Smoking is a main risk factor for bladder cancer (BC). NAT2 is a drug-metabolizing enzyme
that catalyses the detoxification of many xenobiotics and carcinogens. Single nucleotide …

Pharmacogenetics of Drug Therapies in Rheumatoid Arthritis

A Aluko, P Ranganathan - Pharmacogenomics in Drug Discovery and …, 2022 - Springer
Rheumatoid arthritis (RA) is a chronic systemic inflammatory disorder that can lead to severe
joint damage and is often associated with a high morbidity and disability. Disease-modifying …